Renaissance in the Lifesciences Sector: Bharat Book Bureau
promotes the Lifesciences and Private Equity Conference to
be held on 14th-15th November, 2006 at
the ITC Grand Maratha Sheraton, Mumbai.
An
exclusive two day conference, which provides a platform for
the investors as well as industry players.
Bharat Book Bureau
is proud to promote the Lifesciences and Private Equity
conference, organized by IVCJ , which is purely focused on
the exciting Lifesciences industry. Private Equity has been
a noteworthy catalyst of entrepreneurial activity in the
pharmaceutical industry. Existing and would-be entrepreneurs
and technocrats seriously considering the risk capital route
need to understand the expectations of the VC&PE community
and bring forward well thought-out business strategies to
their table for consideration. On the other side of the
coin, the VC&PE community and investors need to understand
the returns and challenges of the Lifesciences industry to
be able to hone in to the right deals. This exclusive
two-day conference, the first of its kind in India, provides
a platform for investors and industry players alike to
discuss and plan their strategies around a totally new risk
and returns milieu. IVCJ aims to bring out an absolute
picture of the VC&PE activity taking place in all the 3
sections of lifesciences, namely
pharmaceuticals,
biotechnology and
healthcare.
It also aims to bring key decision makers from the of VC&PE
and Lifesciences industries to facilitate discussion on key
issues and create a conducive networking environment.
Private Equity
investments have also seen record growth of about 85% from
$1.1 billion in 2004 to $ 2.03 billion in 2005. The VC&PE
community's buoyant confidence in this sector was evident by
the fact that the LifeSciences sector emerged as one of the
leading recipients of funds accounting for 18% share of all
VC&PE investments in 2005.
The Lifesciences Sector
is a key growth driver of India 's economy and the year 2005
will go down as the year of renaissance for the Lifesciences,
bringing fresh vitality and vigour to the industry.
Compliance with the TRIPS mandate at the beginning of 2005
has revolutionized the very identity of Indian
pharmaceuticals and thrust it down the path of innovation.
Today, India Inc. has become an integral part of the global
Lifesciences market with a growing share in this space. Cost
arbitrage and high quality capabilities are shifting global
pharmaceutical attention to India, which could soon make it
the pharmaceutical manufacturing hub of the world.
Accelerated inroads into the biotech space and a healthcare
industry on the verge of a boom, are attracting soaring
global awareness presenting a plethora of opportunities.
AIMS
AND OBJECTIVES
-
to analyse the
growth trend and opportunities in the Lifesciences sector.
-
to gather
experts from the industry to expand on the issues
confronted by them and solutions that have been deployed.
-
to discuss the
challenges in deployment of Private Equity for all the
segments of the Lifesciences sector.
-
to discuss
issues relating to legal, regulatory and tax pertaining to
the lifescience sectors.
-
to understand
the perspectives of investees and investors on Valuation
and Due diligence.
-
to provide a
unique opportunity to meet and network with decision
makers and key players of the industry and the VC & PE
community.
WHO
SHOULD ATTEND
-
Promoters and
Senior Executives of the Lifescience sector
-
PE & VC
Practitioners
-
Fund Managers
& HNI Investors
-
Legal
Counsellors & Advisors
-
Consultants &
Analysts
Kindly click here for more information about this report
